Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Transdermal N-0923 effective in Parkinson's disease

May 6, 1997

COX-2 inhibitor shows potential for preventing neuronal death

May 6, 1997

FDA clears generic version of SKB's Compazine

May 6, 1997

Clinical efficacy of Myotrophin in ALS and postpolio syndrome

May 6, 1997

ABT-431 evaluated in Parkinson's patients

May 6, 1997

Progress report on Cypros's adenosine and neuronal calcium channel preclinical programs

May 6, 1997

Neurotrophic factor gene therapy shows promise for motor neuron diseases

May 6, 1997

Daiichi and Fuji prepare new analgesics

May 6, 1997

AMPA/NMDA receptor antagonists from Rhone-Poulenc Rorer

May 6, 1997

Hyal's Oralease receives Emergency Drug Release status in Canada

May 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...